Literature DB >> 22714395

Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs.

Mattia Capulli1, Adriano Angelucci, Keltouma Driouch, Teresa Garcia, Philippe Clement-Lacroix, Francesco Martella, Luca Ventura, Mauro Bologna, Stefano Flamini, Oreste Moreschini, Rosette Lidereau, Enrico Ricevuto, Maurizio Muraca, Anna Teti, Nadia Rucci.   

Abstract

Bone is the preferential site of distant metastasis in breast carcinoma (BrCa). Patients with metastasis restricted to bone (BO) usually show a longer overall survival compared to patients who rapidly develop multiple metastases also involving liver and lung. Hence, molecular predisposition to generate bone and visceral metastases (BV) represents a clear indication of poor clinical outcome. We performed microarray analysis with two different chip platforms, Affymetrix and Agilent, on bone metastasis samples from BO and BV patients. The unsupervised hierarchical clustering of the resulting transcriptomes correlated with the clinical progression, segregating the BO from the BV profiles. Matching the twofold significantly regulated genes from Affymetrix and Agilent chips resulted in a 15-gene signature with 13 upregulated and two downregulated genes in BV versus BO bone metastasis samples. In order to validate the resulting signature, we isolated different MDA-MB-231 clonal subpopulations that metastasize only in the bone (MDA-BO) or in bone and visceral tissues (MDA-BV). Six of the signature genes were also significantly upregulated in MDA-BV compared to MDA-BO clones. A group of upregulated genes, including Hemoglobin B (HBB), were involved in oxygen metabolism, and in vitro functional analysis of HBB revealed that its expression in the MDA subpopulations was associated with a reduced production of hydrogen peroxide. Expression of HBB was detected in primary BrCa tissue but not in normal breast epithelial cells. Metastatic lymph nodes were frequently more positive for HBB compared to the corresponding primary tumors, whereas BO metastases had a lower expression than BV metastases, suggesting a positive correlation between HBB and ability of bone metastasis to rapidly spread to other organs. We propose that HBB, along with other genes involved in oxygen metabolism, confers a more aggressive metastatic phenotype in BrCa cells disseminated to bone.
Copyright © 2012 American Society for Bone and Mineral Research.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22714395     DOI: 10.1002/jbmr.1686

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  14 in total

1.  Hsp90 chaperones hemoglobin maturation in erythroid and nonerythroid cells.

Authors:  Arnab Ghosh; Greer Garee; Elizabeth A Sweeny; Yukio Nakamura; Dennis J Stuehr
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-22       Impact factor: 11.205

Review 2.  Hemoglobin: a nitric-oxide dioxygenase.

Authors:  Paul R Gardner
Journal:  Scientifica (Cairo)       Date:  2012-12-19

3.  Non-conventional role of haemoglobin beta in breast malignancy.

Authors:  Marco Ponzetti; Mattia Capulli; Adriano Angelucci; Luca Ventura; Simona Delle Monache; Cinzia Mercurio; Alessia Calgani; Patrizia Sanità; Anna Teti; Nadia Rucci
Journal:  Br J Cancer       Date:  2017-08-03       Impact factor: 7.640

Review 4.  Switching Homes: How Cancer Moves to Bone.

Authors:  Marco Ponzetti; Nadia Rucci
Journal:  Int J Mol Sci       Date:  2020-06-09       Impact factor: 5.923

5.  Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry.

Authors:  Mattia Capulli; Dayana Hristova; Zoé Valbret; Kashmala Carys; Ronak Arjan; Antonio Maurizi; Francesco Masedu; Alfredo Cappariello; Nadia Rucci; Anna Teti
Journal:  Br J Cancer       Date:  2019-06-26       Impact factor: 7.640

6.  Oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAs.

Authors:  Yves A Lussier; Nikolai N Khodarev; Kelly Regan; Kimberly Corbin; Haiquan Li; Sabha Ganai; Sajid A Khan; Jennifer L Gnerlich; Jennifer Gnerlich; Thomas E Darga; Hanli Fan; Oleksiy Karpenko; Philip B Paty; Mitchell C Posner; Steven J Chmura; Samuel Hellman; Mark K Ferguson; Ralph R Weichselbaum
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

7.  The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures.

Authors:  Jessica G Cockburn; Robin M Hallett; Amy E Gillgrass; Kay N Dias; T Whelan; M N Levine; John A Hassell; Anita Bane
Journal:  BMC Cancer       Date:  2016-07-28       Impact factor: 4.430

8.  Intratumoral acidosis fosters cancer-induced bone pain through the activation of the mesenchymal tumor-associated stroma in bone metastasis from breast carcinoma.

Authors:  Gemma Di Pompo; Silvia Lemma; Lorenzo Canti; Nadia Rucci; Marco Ponzetti; Costantino Errani; Davide Maria Donati; Shonagh Russell; Robert Gillies; Tokuhiro Chano; Nicola Baldini; Sofia Avnet
Journal:  Oncotarget       Date:  2017-04-13

9.  Expression of β-globin by cancer cells promotes cell survival during blood-borne dissemination.

Authors:  Yu Zheng; David T Miyamoto; Ben S Wittner; James P Sullivan; Nicola Aceto; Nicole Vincent Jordan; Min Yu; Nezihi Murat Karabacak; Valentine Comaills; Robert Morris; Rushil Desai; Niyati Desai; Erin Emmons; John D Milner; Richard J Lee; Chin-Lee Wu; Lecia V Sequist; Wilhelm Haas; David T Ting; Mehmet Toner; Sridhar Ramaswamy; Shyamala Maheswaran; Daniel A Haber
Journal:  Nat Commun       Date:  2017-02-09       Impact factor: 14.919

10.  Cytoplasmic Increase in Hsp70 Protein: A Potential New Biomarker of Early Infiltration of Cutaneous Squamous Cell Carcinoma Arising from Actinic Keratosis.

Authors:  Montserrat Fernández-Guarino; José Javier Zamorano León; Antonio José López Farré; Maria Luisa González Morales; Ana Isabel Sánchez Adrada; José Barrio Garde; Jose Antonio Arias Navalon; Pedro Jaén Olasolo
Journal:  Cancers (Basel)       Date:  2020-05-03       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.